⚔️Gold and silver futures prices have surged; what are your thoughts on the future?
Hi，Tigers：💰
Did you make any money? Share your thoughts!🎯
Catch up fast：These events rocked the markets today.
Tiger Community TOP10 Tickers
🎯 S&P500 Most Active Today 👉@TigerObserver
Weekly Five Key Areas: Macro, Singapore Stocks, Options, Futures, Earnings
Covering five major market segments this week to help you stay ahead of market trends and plan your trades effectively!
✨Tuesday — Singapore Stocks
Singapore stocks opened flat on Tuesday.
CapitaLand Investment (CLI): Bursa-listed CapitaLand Malaysia Trust (CLMT) has agreed to buy five high-specification industrial facilities in the Johor-Singapore Special Economic Zone for RM220.8 million (S$69.2 million), said CLI on Monday. The acquisition supports CLMT’s strategy to expand its industrial and logistics portfolio with high-quality assets in an established location, said the chief executive of CapitaLand Malaysia Reit Management, a wholly owned subsidiary of CLI that manages CLMT. CLI shares closed 0.7 per cent or S$0.02 down at S$2.67, before the news.
Ever Glory United: The Catalist-listed engineering services provider will transfer to the mainboard of the Singapore Exchange on Dec 29, as the proposed move received shareholder approval at the company’s extraordinary general meeting on Monday. The company said on Monday that trading in its shares on the mainboard will commence at 9 am on Dec 29. The counter closed 1.4 per cent or S$0.01 higher at S$0.73, before the news.
📌【Today’s Question】
Christmas trading begins, which stocks are you bullish on?
Join the Topic & Win Tiger Coins! >>
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Oral GLP-1 drugs are expected to capture about 25% of the projected $150 billion obesity market, appealing to patients who prefer pills over injections. Novo Nordisk’s tablet showed strong efficacy, with patients losing an average of 16.6% of body weight in trials, supporting semaglutide’s clinical strength.
For Novo Nordisk, the Wegovy pill offers a critical first-mover advantage amid rising competition. With analysts projecting nearly $2 billion in annual sales by 2030, this approval strengthens NVO’s long-term position in the global obesity market.
@Tiger_comments @TigerStars
I have seen so many people look emaciated and sallow (if I had to guess, this is the problem of the 2 big names of the Wicked movie franchise)
GLP1 can be a good thing especially for the obese and the diabetic, but not controlling it properly is a huge problem. Preying on people's insecurity to make big money is not the way to go.
And seriously, the competition would only heat up, with Eli Lilly making their own jab, Chinese companies producing cheap knockoffs, and the companies in the US that stepped up production when Novo could not keep up with demand.
If we are really looking at Novo to go further, I question their viability for the long term.
凯德置地投资（CLI）：CLI周一表示，在证券交易所上市的凯德置地马来西亚信托（CLMT）已同意以2.208亿令吉（6920万新元）购买柔佛-新加坡经济特区的五个高规格工业设施。管理CLMT的CLI全资子公司凯德置地马来西亚房地产投资信托管理公司首席执行官表示，此次收购支持了CLMT在成熟地点利用优质资产扩大其工业和物流投资组合的战略。消息传出前，CLI股价收盘下跌0.7%或0.02新元，至2.67新元。